Zobrazeno 1 - 4
of 4
pro vyhledávání: '"G. G. A. van Lieverloo"'
Autor:
G. G. A. van Lieverloo, A. Al‐Soudi, L. Wieske, P. L. Klarenbeek, D. C. Anang, M. E. Adrichem, I. Niewold, B. D. C. van Schaik, A. H. C. van Kampen, I. N. van Schaik, N. de Vries, F. Eftimov
Publikováno v:
Journal of the peripheral nervous system, 28(1), 69-78. Wiley-Blackwell
The immunopathophysiological mechanisms underlying chronic inflammatory demyelinating polyneuropathy (CIDP) in an individual patient are largely unknown. Better understanding of these mechanisms may aid development of biomarkers and targeted therapie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b060949a6429887cfe16e47c51f3283b
https://doi.org/10.1111/jns.12533
https://doi.org/10.1111/jns.12533
Autor:
P.A. van Doorn, W.L. van der Pol, H S Goedee, I. N. van Schaik, Max E. Adrichem, Hester F. Lingsma, S. R. M. Bus, R. van der Veen, Bart C. Jacobs, Merel C. Broers, Ilse M. Lucke, G. G. A. van Lieverloo, Carina Bunschoten, Luuk Wieske, Filip Eftimov
Publikováno v:
Journal of Neurology, 269(2), 945-955. D. Steinkopff-Verlag
Journal of Neurology
Journal of Neurology
Objective To assess clinical outcome in treatment-naive patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Methods We included adult treatment-naive patients participating in the prospective International CIDP Outcome Stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73c57afcfd01cbdd8d4057b54b99bd1b
https://pure.eur.nl/en/publications/2849943e-ce21-4132-8d28-6c64469113ec
https://pure.eur.nl/en/publications/2849943e-ce21-4132-8d28-6c64469113ec
Autor:
Francesca Gallia, Camiel Verhamme, Ivana Basta, I. N. van Schaik, Eduardo Nobile-Orazio, Pietro Emiliano Doneddu, Stojan Peric, Ana Nikolic, Luuk Wieske, Filip Eftimov, G. G. A. van Lieverloo
Publikováno v:
Journal of neurology, 265(9), 2052-2059. D. Steinkopff-Verlag
Background: Chronic inflammatory demyelinating polyneuropathy (CIDP) can be treated with corticosteroids or intravenous immunoglobulins. Various corticosteroid regimens are currently used in CIDP, but it is unknown whether they are equally efficaciou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adc216e94ab189fea3820a1a5d4a39d4
https://doi.org/10.1007/s00415-018-8948-y
https://doi.org/10.1007/s00415-018-8948-y
Autor:
L. van der Hoek, Luuk Wieske, G. G. A. van Lieverloo, I. N. van Schaik, Martin Deijs, Filip Eftimov
Publikováno v:
Journal of neuroimmunology, 358:577668. Elsevier
The events triggering and/or sustaining the auto-immune response underlying chronic inflammatory demyelinating polyneuropathy (CIDP) are unknown. Similar to Guillain-Barre syndrome (GBS), a viral infection might play a role in CIDP. In this study, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49f31097660d9fdb45247e372f7ad849
https://doi.org/10.1016/j.jneuroim.2021.577668
https://doi.org/10.1016/j.jneuroim.2021.577668